29th Mar 2005 16:15
AstraZeneca PLC29 March 2005 Dealing by Directors Companies Act 1985 Sections 324/329 We hereby inform you that on 24 March 2005 the following Directors ofAstraZeneca PLC were granted options under the AstraZeneca Share Option Planover the Company's USD0.25 Ordinary Shares. Number of shares over which option is Exercise price per Period when Total number of sharesName of Director granted share exercisable under option Sir Tom McKillop 131,707 2132p 24.3.08-23.3.15 679,058 J R Symonds 60,196 2132p 24.3.08-23.3.15 313,051 J S Patterson 52,908 2132p 24.3.08-23.3.15 197,082 The options will become exercisable on 24 March 2008 subject to certainperformance conditions. The conditions, which will not be subject to anyretesting, are that the earnings per share of the Company must increase by theincrease in the UK Retail Prices Index plus 5% per annum on average over threeyears, and that no significant unforeseen event has taken place which, in thereasonable opinion of the Remuneration Committee, has resulted in majorreputational damage to AstraZeneca, and the circumstances of which areexceptional enough to justify the option not vesting and becoming exercisable.Failure to satisfy either or both of these conditions will result in the lapseof the option in its entirety. G H R MuskerCompany Secretary29 March 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca